NANO-X IMAGING LTD (NNOX) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TELA Bio (TELA) has outperformed NANO-X IMAGING LTD (NNOX) over the past year, losing 31.4% versus a loss of 86.9%. Over five years, TELA leads with a -91.7% price change compared with -97.5% for NNOX. TELA Bio is the larger company by market cap ($50.1 million vs $42.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NNOX | TELA |
|---|---|---|
| Share price | $0.5378 | $1.11 |
| Market cap | $42.26M | $50.11M |
| 1-day change | -5.03% | +5.71% |
| YTD return | -79.77% | -11.02% |
| 1-year return | -86.92% | -31.37% |
| 5-year return | -97.51% | -91.67% |
| EPS (TTM) | $-1.72 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.71 | $1.56 |
| 52-week low | $0.5314 | $0.501 |
| Distance from 52-week high | -88.57% | -28.85% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +667.94% | +87.39% |
| Average volume | 1.15M | 214.83K |
| Shares outstanding | 78.59M | 45.14M |
| Employees | 197 | 218 |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELA has outperformed NNOX by 55.5 percentage points over the past year.
About NANO-X IMAGING LTD
NNOX stock →Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source.
Health Care · Medical Electronics · 197 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
NNOX vs TELA FAQ
Which is bigger, NANO-X IMAGING LTD or TELA Bio?
TELA Bio (TELA) is larger, with a market capitalization of $50.11M compared with $42.26M for NANO-X IMAGING LTD (NNOX).
Which stock has performed better over the past year, NNOX or TELA?
TELA returned -31.37% over the past 12 months, compared with -86.92% for NNOX (price return, excluding dividends). Past performance does not predict future results.
Are NANO-X IMAGING LTD and TELA Bio in the same industry?
Both are in the Health Care sector, but in different industries: Medical Electronics for NANO-X IMAGING LTD and Medical/Dental Instruments for TELA Bio.